Archives
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-11
- 2018-10
- 2018-07
-
Z-VAD-FMK (Benzyloxycarbonyl-Val-Ala-Asp(OMe)-FMK): Reliable
2026-04-22
This article provides scenario-driven guidance for leveraging Z-VAD-FMK (Benzyloxycarbonyl-Val-Ala-Asp(OMe)-fluoromethylketone, SKU A1902) in cell viability, proliferation, and cytotoxicity assays. Drawing on current literature and validated protocols, it addresses common laboratory challenges and demonstrates how SKU A1902 from APExBIO delivers robust, reproducible results in apoptosis inhibition and caspase pathway research.
-
Ziprasidone Augmentation in Anxious Depression: Efficacy Ins
2026-04-21
A recent randomized controlled trial assessed whether augmenting SSRI therapy with ziprasidone hydrochloride delivers additional benefits for patients with anxious versus nonanxious depression. The study found that ziprasidone augmentation produced similar antidepressant effects in both groups, with no clinically significant anxiolytic advantage for those with anxious depression.
-
RIG-I Drives Renal Fibrosis via c-Myc in UUO: Mechanistic In
2026-04-21
This study elucidates how RIG-I amplifies renal interstitial fibrosis by activating c-Myc-mediated fibroblast signaling in murine UUO and FA models. The findings clarify the inflammatory-fibrotic axis and identify actionable molecular targets for experimental kidney disease models.
-
EZ Cap Cy5 Firefly Luciferase mRNA: Precision for mRNA Deliv
2026-04-20
EZ Cap Cy5 Firefly Luciferase mRNA (5-moUTP) sets a new benchmark for dual-mode mRNA delivery, enabling simultaneous fluorescence tracking and bioluminescence quantification in a single workflow. Its Cap1 structure and 5-moUTP modifications directly address translation efficiency and innate immune suppression, making it a top-tier choice for advanced cell-based, in vivo imaging, and vaccine research.
-
Epidermal Growth Factor: Applied Use-Cases & Workflow Master
2026-04-20
Recombinant human EGF unlocks advanced cell proliferation and stemness assays, providing reproducible, high-purity signaling for cutting-edge cancer and regenerative studies. Discover best-practice workflows and troubleshooting strategies that set your research apart.
-
Chlorambucil in Precision Oncology: Assay Design and Data In
2026-04-19
Explore how Chlorambucil, a nitrogen mustard alkylating agent, drives assay innovation and precision data interpretation in cancer research. This article uniquely bridges mechanistic insights with advanced experimental design, providing actionable guidance for researchers.
-
I-BET-762: BET Inhibitor Workflows for Inflammation & Cancer
2026-04-18
I-BET-762 is a nanomolar-potency BET inhibitor with validated utility in modulating ferroptosis, transcriptional regulation, and inflammatory responses. This article details actionable protocols, troubleshooting strategies, and new evidence for maximizing its impact in preclinical cancer and inflammation models.
-
Distinct Mechanisms of AKT Inhibitors: Insights for DNA Repa
2026-04-17
This article reviews a systematic study of AKT inhibitors, highlighting structural and pharmacological differences between ATP-competitive and allosteric compounds. The findings inform the design of combination therapies and have implications for optimizing DNA repair and oncology research strategies.
-
Machine Learning-Guided LNPs for mRNA Delivery to Microglia
2026-04-16
This study introduces a machine learning-assisted platform to optimize immunomodulatory lipid nanoparticles (LNPs) for efficient mRNA delivery to hyperactivated microglia. By leveraging a combinatorial library and neural network models, the work identifies HA-modified LNPs that repolarize inflammatory microglia, providing new directions for mRNA-based neuroimmunomodulation.
-
Epmedin C Counters DON-Induced Immunotoxicity in Chicken Mac
2026-04-15
This study identifies epmedin C, a flavonoid from Epimedium, as a potent inhibitor of caspase-1 activation, effectively reducing deoxynivalenol (DON)-induced immunotoxicity in chicken macrophages. The research demonstrates both in vitro and in vivo how epmedin C mitigates oxidative stress and restores immune function, offering valuable insights for mycotoxin detoxification strategies in poultry.
-
Arginine Methylation Drives FUS–SMN Phase Separation in Neur
2026-04-14
Wang and Li (2024) reveal that arginine methylation of FUS enables multivalent interactions with SMN, promoting the phase separation essential for neuronal granule formation. These findings clarify the molecular logic of RNA transport in neurons and highlight new mechanisms relevant to neurodegeneration.
-
RESTRICT-seq Reveals KAT6A Dependency in SCC Resistance Mech
2026-04-13
The RESTRICT-seq study introduces a time-gated CRISPR screening approach to uncover epigenetic dependencies in squamous cell carcinoma (SCC) resistance. Notably, the research identifies KAT6A as a critical epigenetic vulnerability, refining our understanding of oncogene-induced senescence and informing future assay design.
-
CK2 and ERK8 Inhibitor: Precision Control for Phase Separati
2026-04-13
Explore the scientific impact of 2-(4,5,6,7-tetrabromo-2-(dimethylamino)-1H-benzo[d]imidazol-1-yl)acetic acid, a potent small molecule inhibitor. Learn how this molecular tool advances phase separation research and kinase regulation beyond conventional approaches.
-
GSK J4 HCl: JMJD3 Inhibitor Workflows for Epigenetic Researc
2026-04-12
GSK J4 HCl, a potent JMJD3 inhibitor from APExBIO, unlocks precise control of histone demethylation in inflammation and cancer models. This guide distills advanced workflows, troubleshooting tactics, and translational insights from benchmark studies, empowering researchers to maximize both experimental rigor and discovery impact.
-
Indometacin Sodium: Protocols & Pitfalls in Anti-Inflammator
2026-04-12
Indometacin Sodium Trihydrate empowers inflammation, pain, and neuroregenerative research with validated protocols and high solubility. This guide delivers practical workflows, troubleshooting insights, and data-backed tips for maximizing reproducibility and translational relevance.